Literature DB >> 24928915

Increased internalization of Staphylococcus aureus and cytokine expression in human Wharton's jelly mesenchymal stem cells.

Jérôme Josse1, Frédéric Velard2, Saad Mechiche Alami3, Valérie Brun4, Christine Guillaume3, Halima Kerdjoudj3, Bouchaib Lamkhioued1, Sophie C Gangloff1.   

Abstract

BACKGROUND: Although a large number of studies have documented the interaction of mesenchymal stem cells (MSCs) with cells of both the innate and adaptive immune systems, not much is known about how bacteria interact with MSCs and how this might influence MSCs behavior. In this study, we investigated the impact of Staphylococcus aureus (S. aureus), on viability and cytokines' production of human Wharton's jelly-MSCs (WJ-MSCs).
OBJECTIVE: To investigate if WJ-MSCs: (1) internalize S. aureus; (2) are able to survive and (3) release immunomodulatory mediators after interaction with S. aureus.
METHODS: WJ-MSCs were exposed to S. aureus at a multiplicity of infection (MOI) of 10:1 or 30:1 for different designed times. After interaction, intracellular bacteria were quantified as well as MSCs viability. Expression and cytokine-secretion were assessed using quantitative real-time PCR and ELISA.
RESULTS: We found that the challenge of WJ-MSCs with S. aureus resulted in increased internalization of S. aureus in a time-dependent manner until six hours post-infection at either MOI of 10:1 and 30:1 and in increased expression of IL-6 mRNA and secretion of TNF-α at six hours and nine hours post-infection (p<0.05).
CONCLUSIONS: These results indicate that WJ-MSCs are able to internalize S. aureus and reveal a potential important function of these cells in the immune response.

Entities:  

Keywords:  Human Wharton's jelly stem cells (WJ-MSCs); Staphylococcus aureus (S. aureus); inflammation; internalization

Mesh:

Substances:

Year:  2014        PMID: 24928915     DOI: 10.3233/BME-140971

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  6 in total

1.  Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes.

Authors:  Jianxia Hu; Yangang Wang; Huimin Gong; Chundong Yu; Caihong Guo; Fang Wang; Shengli Yan; Hongmei Xu
Journal:  Exp Ther Med       Date:  2016-07-26       Impact factor: 2.447

Review 2.  Exploring the roles of MSCs in infections: focus on bacterial diseases.

Authors:  Pasquale Marrazzo; Annunziata Nancy Crupi; Francesco Alviano; Laura Teodori; Laura Bonsi
Journal:  J Mol Med (Berl)       Date:  2019-02-07       Impact factor: 4.599

3.  Minocycline modulates NFκB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal/stem cells.

Authors:  Alberto Daniel Guerra; Warren E Rose; Peiman Hematti; W John Kao
Journal:  Stem Cell Res Ther       Date:  2017-07-21       Impact factor: 6.832

Review 4.  The Crossroads between Infection and Bone Loss.

Authors:  Tiago Carvalho Oliveira; Maria Salomé Gomes; Ana Cordeiro Gomes
Journal:  Microorganisms       Date:  2020-11-10

5.  Impact of the Maturation of Human Primary Bone-Forming Cells on Their Behavior in Acute or Persistent Staphylococcus aureus Infection Models.

Authors:  Jérôme Josse; Christine Guillaume; Camille Bour; Flora Lemaire; Céline Mongaret; Florence Draux; Frédéric Velard; Sophie C Gangloff
Journal:  Front Cell Infect Microbiol       Date:  2016-06-21       Impact factor: 5.293

6.  Mast cells-derived MiR-223 destroys intestinal barrier function by inhibition of CLDN8 expression in intestinal epithelial cells.

Authors:  Musheng Li; Junhong Zhao; Meiwan Cao; Ruitao Liu; Guanhua Chen; Songyu Li; Yuanwen Xie; Jing Xie; Yang Cheng; Ling Huang; Mingmin Su; Yuxin Xu; Mingyue Zheng; Kejian Zou; Lanlan Geng; Wanfu Xu; Sitang Gong
Journal:  Biol Res       Date:  2020-03-24       Impact factor: 5.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.